Florian Krammer on X: "For everybody worried that RNA vaccines are now tested for the first time in humans. That is actually not the case. See list below. It is true that
Safety of COVID-19 Vaccines
Unlocking the promise of mRNA therapeutics | Nature Biotechnology
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine
COVID-19 Vaccine: Addressing Your Concerns - Student Wellness Centre - Trent University
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine | NEJM
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications
COVID19 vaccines... - Pennsylvania Department of Health | Facebook
Health Alert on mRNA COVID-19 Vaccine Safety | Florida Department of Health
COVID-19 vaccines and their long-term safety - Curious
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy
COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The
Three things to know about the long-term side effects of COVID vaccines - News | UAB
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications
Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
Frontiers | Advances in mRNA Vaccines for Infectious Diseases
Are MRNA Vaccines Safe | COVID-19 Prevention Network
Unlocking the promise of mRNA therapeutics | Nature Biotechnology
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology
IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery
